400
Participants
Start Date
March 7, 2022
Primary Completion Date
October 23, 2024
Study Completion Date
October 23, 2024
Immunology and Pathogenesis Laboratories, Bethesda
Maferinyah Rural Health Training and Research Center, Maferinyah
National Institute of Allergy and Infectious Diseases (NIAID)
NIH